{"id":"NCT01197508","sponsor":"AstraZeneca","briefTitle":"A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.","officialTitle":"A Multicenter, Randomized, Double-Blind Parallel Group Placebo-Controlled Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressants in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2010-09-09","resultsPosted":"2012-10-29","lastUpdate":"2014-04-11"},"enrollment":696,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"TC-5214","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"0.1 mg BID TC-5214","type":"EXPERIMENTAL"},{"label":"1 mg BID TC-5214","type":"EXPERIMENTAL"},{"label":"4 mg BID TC-5214","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like a medicine tablet or capsule, but contains no active medicine) is safe and effective when taken together with another antidepressant.","primaryOutcome":{"measure":"Change in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score From Randomization to End of Treatment.","timeFrame":"Randomization (Week 8) to end of treatment (Week 16)","effectByArm":[{"arm":"0.1 mg BID TC-5214","deltaMin":-11.6,"sd":0.65},{"arm":"1 mg BID TC-5214","deltaMin":-12.2,"sd":0.66},{"arm":"4 mg BID TC-5214","deltaMin":-12.2,"sd":0.69},{"arm":"Placebo","deltaMin":-12.7,"sd":0.65}],"pValues":[{"comp":"OG000 vs OG003","p":"1.000"},{"comp":"OG001 vs OG003","p":"1.000"},{"comp":"OG002 vs OG003","p":"1.000"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":87,"countries":["Argentina","Brazil","Bulgaria","Chile","Colombia","Croatia","France","Germany","Hungary","Poland","Romania","Russia","Serbia","Slovakia","South Africa","Spain","Ukraine"]},"refs":{"pmids":["25602163"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=336&filename=CSR-D4130C00005.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=336&filename=D4130C00005_Revised_CSP_1_redacted.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":174},"commonTop":["Headache","Constipation","Dizziness","Nausea","Dry Mouth"]}}